439
Participants
Start Date
February 14, 2022
Primary Completion Date
August 2, 2024
Study Completion Date
February 28, 2029
177Lu-PSMA-I&T
Radioligand therapy
Abiraterone with Prednisone or Enzalutamide
Hormone Therapy
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center - Herbert Irving Pavilion, New York
SUNY Upstate Medical University, Syracuse
MidLantic Urology, Bala-Cynwyd
Kaiser Permanente Gaithersburg Medical Center, Gaithersburg
John Hopkins Hospital, Baltimore
Orlando Health Cancer Institute, Orlando
Biogenix Molecular LLC, Miami
GenesisCare USA, Plantation
GenesisCare USA, Boca Raton
Florida Urology Partners, LLP, Tampa
Central Ohio Urology Group, Gahanna
Michigan Institute of Urology, Troy
GenesisCare USA, Troy
Henry Ford Hospital, Detroit
BAMF Health I PC, Grand Rapids
M Health Fairview Ridges Cancer Clinic, Burnsville
NorthShore University HealthSystem-Evanston Hospital, Evanston
Northwestern Memorial Hospital, Chicago
SSM Saint Louis University Hospital, St Louis
Center for Clinical Theranostics Research, Washington University, St Louis
Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha
XCancer Omaha / Urology Cancer Center, Omaha
Hightower Clinical, Oklahoma City
Houston Metro Urology, Houston
Urology San Antonio, San Antonio
Arizona Institute of Urology, PPLC, Tucson
Providence Saint John's Health Center, Santa Monica
Long Beach Memorial Center, Long Beach
Hoag Memorial Hospital Presbyterian, Newport Beach
Providence Medical Foundation, Fullerton
San Francisco VA Health Care System, San Francisco
University of California, San Francisco, San Francisco
OHSU - Center for health and healing, Portland
VA Portland Health Care System, Portland
Fred Hutchinson Cancer Center, Seattle
Rutgers Cancer Institute of New Jersey, New Brunswick
CHU Brest, Brest
Jean Perrin Comprehensive Cancer Center, Clermont-Ferrand
Institute Paoli-Calmettes, Marseille
Hôpital de Brabois -CHU, Nancy
Institut de Cancérologie de l'Ouest (ICO) St Herblain, Nantes
CHU Nimes, Nîmes
ICANS, Strasbourg
InstitutClaudius Regaud-IUCT-O, Toulouse
University Clinic Bologna, Bologna
ASST Grande Ospedale Metropolitano Niguarda, Milan
Istituto Europeo di Oncologia (IEO) -IRCCS, Milan
Fundación Jiménez Díaz, Madrid
Hospital Universitario HM Sanchinarro, Madrid
Hospital Regional Universitario de Malaga, Málaga
University Hospital of Salamanca, Salamanca
Curium US LLC
INDUSTRY